By: IPP Bureau
Last updated : November 23, 2025 5:52 pm
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
Croda International has announced a strategic supply partnership with Amino GmbH to expand its biopharma capabilities, specifically in the supply of high-purity, pharmaceutical-grade amino acids.
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids. This will enable Croda to deliver even more innovative, high-quality and sustainable solutions that help customers accelerate their product development and achieve greater efficiency.
"This partnership reflects Croda’s strategy, to strengthen our ability to support customers in the fast-evolving biopharma landscape” said Katie Dec, Global Business Director, Croda International. "Amino’s strong reputation and expertise make them an ideal partner as we continue to deliver high-quality, reliable materials needed to bring new therapies to market.”
“The partnership with Croda is both a milestone and a catalyst for Amino’s ambitions in biopharmaceuticals. The combination of Croda’s market reach and our high-purity amino acid production expertise forms a partnership dedicated to meeting specific customer demands,” states Lutz Thomas, Managing Director of Amino GmbH.